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Amechanistic role for leptin in human dendritic cell
migration: differences between ileum and colon in
health and Crohn’s disease
HO Al-Hassi1, D Bernardo1, AU Murugananthan1, ER Mann1, NR English1, A Jones1, MA Kamm2,3,
N Arebi1, AL Hart1, AIF Blakemore4, AJ Stagg5 and SC Knight1
Dendritic cells (DC) migrate to lymph nodes on expression of C-C motif chemokine receptor 7 (CCR7) and control
immune activity. Leptin, an immunomodulatory adipokine, functions via leptin receptors, signaling via the long isoform
of receptor, LepRb. Leptin promotesDCmaturation and increasesCCR7expressiononbloodDC. Increasedmesenteric
fat and leptin occur early in Crohn’s disease (CD), suggesting leptin-mediated change in intestinal CCR7 expression on
DC as a pro-inflammatory mechanism. We have demonstrated CCR7 expression and capacity to migrate to its ligand
macrophage inflammatory protein 3b in normal human ileal DC but not colonic or blood DC. In CD, functional CCR7was
expressed on DC from all sites. Only DC populations containing CCR7-expressing cells produced LepRb; in vitro
exposure to leptin also increased expression of functional CCR7 in intestinal DC in a dose-dependent manner. In
conclusion, leptin may regulate DC migration from gut, in homeostatic and inflammatory conditions, providing a link
between mesenteric obesity and inflammation.
INTRODUCTION
Dendritic cells (DC) are heterogeneous, potent, antigen-
presenting cells that comprise plasmacytoid and conven-
tional/myeloid (mDC) sub-populations. They are present as
‘‘immature’’ cells specialised for antigen uptake in most tissues
of the body, particularly at the sites of interfacewith the external
environment, such as the skin and mucosae.1 A property that
distinguishes DC from other types of antigen-presenting cell is
their potency in activating naive T cells, an interaction which
generally occurs in secondary lymphoid tissue. Therefore, there
is a requirement for antigen-bearing DC to migrate from the
tissues to draining lymph nodes. In response to infection or
signals that indicate local tissue damage, such as the production
of pro-inflammatory cytokines, this migration of DC is
accompanied by ‘‘maturation’’ in which antigen-acquisition
machinery is downregulated, co-stimulatory molecule expres-
sion is enhanced and the ability to activate naive T cells is
acquired. Furthermore, DC are present in the afferent lymph,
draining the intestine even in the absence of overt inflamma-
tion, and a subset of these DC may be involved in non-
responsiveness.2
Activation or ‘‘maturation’’ of DC populations
generated in vitro is accompanied by a switch in the type
of chemokine receptors expressed by the DC.3 Receptors for
inflammatory-type chemokines, which are probably important
for recruitment of immature DC into tissues in vivo, are
downregulated upon maturation with lipopolysaccharide or
tumor-necrosis factor a (TNFa). These receptors include
C-C motif chemokine receptor 1 (CCR1), CCR2, CCR5,
and CXCR1. By contrast, expression of CCR7, and migra-
tory responses to its ligands, are strongly upregulated
following maturation in vitro.3,4 CCR7 has three known
ligands, CCL19 (macrophage inflammatory protein 3b
(MIP-3b)) and two variants of CCL21 (6-C-kine), CCL21-
Leu and CCL21-Ser, expressed in lymph nodes or lymphatic
endothelia.5
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Observations on DC matured in vitro have led to the
chemokine receptor switch model, which proposes an activa-
tion-linked induction of CCR7, which is critical for the
trafficking of DC to neighboring lymph nodes regardless of
their maturation status.6 Whatever mechanisms drive the
migration of DC in the absence of inflammation, these
constitutively trafficking DC present tissue-specific self-anti-
gens.7 They can have a crucial role in maintaining tolerance by
deleting or silencing potentially autoreactive T cells that have
escaped thymic selection.8
A characteristic symptom of Crohn’s disease (CD) is
hypertrophy of mesenteric fat and fat wrapping the intestine.
This ‘‘creeping’’ fat is the secretion site of biologically active
molecules, known as adipokines,9,10 which act on the immune
system; these adipokines include leptin, adiponectin, resistin,
and visfatin. Leptin is primarily produced by adipocytes and is a
regulator of appetite, limiting food intake. However, leptin also
has a role in regulating immune responses.11 For example, it
promotes maturation and survival of DC by activating nuclear
factor-kB, which has an anti-apoptotic effect on DC.12 Leptin
also improves the ability of DC to stimulate T cells and promote
a T helper type 1 type response.13,14 Furthermore, treatment of
monocyte-derived DC with leptin increases production of
interleukin (IL)-12, IL-6, and IL-1b and downregulates the
production of IL-10, underlining the view of leptin as a
proinflammatory adipokine.12 Hence, studies on leptin func-
tion outside the neuroendocrine axis by targeting cells of the
immune system via its receptor in health and disease has been
suggested.15 Leptin signals via leptin receptors (LepRs), which
exist in several isoforms (LepRa–f); these receptors have
identical extracellular domains, but only the long isoform
LepRb has a long cytoplasm domain and definite signaling
capacity through the Janus kinase (JAK)/STAT (signal
transducer and activator of transcription factor) pathway16,17
and phosphorylation of STAT3 (pSTAT3). The other isoforms
LepRa, c–f have shorter cytoplasm domains and may signal
through the mitogen-activated protein kinase pathway.18,19
The expression pattern of LepRb in the colon and terminal
ileum, and the effects of leptin on DC migration in relation to
CD are still largely unknown.
Accumulating evidence has linked the effect of leptin to DC
migration. For example, leptin upregulates the expression of
CCR7 on immature, peripheral blood DC.20 Moreover, mature
DC from leptin receptor–deficient mice expressed low levels of
CCR7, indicating an impaired migratory function.21 In fact,
leptin andCCR7 signaling have several interlinked functions on
DC; similar to leptin, signaling via PI3-Akt,22 CCR7 prolongs
DC lifespan by activating the anti-apoptotic effect of nuclear
factor-kB.23 They both inducemorphological changes inDC by
inducing regulation and rearrangement of actinmicrofilaments
of the DC cytoskeleton leading to an increase in their veiled
extensions, indicating a positive effect on DC migration and
capacity to capture and stimulate T cells in the lymph
nodes.12,24 These findings suggest a special relationship
between immune cells and mesenteric fat. They raise questions
about local changes in leptin/leptin receptor production in
inflammatory bowel disease (IBD), including whether leptin
has an immunomodulatory effect on DC function in the gut.
The trafficking of DC populations that sample and respond
to microbial products at different sites in the intestine and the
regulation of this trafficking is likely to be a control point in
intestinal responses. However, most studies of gut immunity
are performed in the mouse and more particularly—when
details are given—in the mouse ileum. Extrapolating findings
by generalizations about ‘‘intestinal immunity’’ when only
studying the microbe-poor environment of mouse ileum and
not the microbe-rich colonic regions and in pathogen-free
animals on a defined diet may not be accurate models for
human immunity in different regions of the gut. Thus, we
studied, in humans, the expression and function of CCR7, both
in DC from the microbe-rich colonic environment and in DC
from the relatively microbe-poor terminal ileum. We also
examined whether the action of leptin via LepRb provided a
mechanism for functional CCR7 induction. The possible
involvement of this pathway in gut inflammation in IBD
was also examined. The results provide evidence that
stimulation of CCR7 expression by leptin is involved in
homeostasis in the ileum but is operating in the colon
exclusively in IBD. Hence, DC trafficking is differentially
regulated in the colon and terminal ileum and alterations in
trafficking may contribute to pathology in IBD.
RESULTS
Expression of functional CCR7 by healthy blood and
intestinal human DC
BloodDC. Multi-color flow cytometry was used to identify DC
and to examine CCR7 expression on DC in fresh whole blood.
DC were identified as shown in the Methods section
(Figure 1a), and CCR7 was not detectable on mDC,
whereas, blood plasmacytoid DC expressed CCR7 (Figure 1b).
Intestinal DC—expression of CCR7 differed between ileum
and colon. CCR7 was not detected on most freshly isolated DC
from colonic samples of non-inflamed tissue from control
individuals, but expression was increased on DC from normal
ileum (Po0.0001; Figure 2a). Furthermore, in paired samples
from the same individuals, the expression of CCR7 was
significantly higher on DC from normal ileum compared with
that on normal colonic DC (Po0.001; Figure 2b). Functional
studies showed that ileum DC that expressed CCR7 migrated
towards MIP-3b, a CCR7 receptor chemo-attractant, in
chemotaxis assays and that this migration was
concentration dependent (Figure 2c).
Production of LepRb by ileal and colonic human DC
To assess whether signaling through the leptin receptor might
contribute to the CCR7 expression on DC, we determined the
ongoing production of LepRb by measuring intracellular
accumulation of the LepRb protein in a 4-h in vitro culture of
freshly obtained DC. Production of LepRb mirrored the
expression of CCR7. Thus, there was minimal or undetectable
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ongoing LepRb receptor production in the normal colonic DC.
By contrast, a greater production of LepRb was observed in the
normal ileum using paired samples (colonic and terminal ileum
biopsies) from the same individuals (Po005; Figure 3a).
Expression of pSTAT3 in LepRb-producing DC
We investigated whether LepRb-producing DC expressed
pSTAT3 by assessing the co-expression of both proteins using
flow cytometry. We observed significantly higher intracellular
expression of pSTAT3 on LepRb-producing DC from the
normal ileum than from the colonic DC (Figure 3b).
Changes in CCR7 and LepRb in DC in CD
To assess whether changes in LepRb and the CCR7 migration
marker were relevant to inflammation in CD, we studied both
receptors inDC from the blood and gut (both ileum and colon).
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Figure1 ExpressionofC-Cmotif chemokine receptor 7 (CCR7) on freshly isolatedblooddendritic cells (DC) subsets. TwoDCsubsetswere identified in
blood among the lineage-negative, DR-positive DC: CD11cþ myeloid DC (mDC) and CD11c plasmacytoid DC (pDC). CCR7 was then examined in a
fourth channel. The shaded areas of histograms represent the fraction of CCR7þ DC after subtraction of staining from isotype-matched control (n¼8)
using WinList algorithm (Verity Software, MA).
100
80
60
CC
R7
 %
 +
ve
 D
C
40
20
40
20
15
5
10
25
30
35
45
0 0
200
N
um
be
r o
f m
ig
ra
tin
g 
DC
150
50
100
250
300
0
0 0.05 0.5 5Colon ColonSmall bowel
*** **
Small bowel
MIP3β concentrations μg/ml
Figure 2 Expression ofC-Cmotif chemokine receptor 7 (CCR7) by intestinal dendritic cells (DC). (a) Terminal ileumDC fromnormal individuals (n¼13)
expressedsignificantly higherCCR7 thanDC fromnormal colonic tissues (n¼14). (b)DC fromnormal ileumexpressedsignificantlymoreCCR7 than that
from the normal colon in paired samples from the same individuals (n¼ 4). (c) Migration of CCR7þ DC towards different concentrations of MIP-3b
(macrophage inflammatory protein-3b; n¼4). The statistical significance of differences between groups was determined using unpaired t-test for
comparison in a and paired t-tests for comparisons in b and c. Po0.05 was regarded as significant.
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In marked contrast to the low levels of expression of CCR7 on
normal blood and colonic DC, both blood and colonic DC from
CD patients expressed CCR7. In the inflamed colon, CCR7
levels on DC were significantly higher than those on normal
colonic DC (Po0.001; Figure 4a). Similarly, blood DC from
patients with CD expressed significantly higher levels of CCR7
than those from normal individuals (Po0.0001; Figure 4b).
DC from the colon and blood in CD were also producing
LepRb. Thus, LepRb production was significantly increased in
DC from colonic biopsies from patients with CD compared
with the minimal-to-undetectable production in DC from
control colonic biopsies (Po0.0001; Figure 4c) and also
significantly increased in DC from peripheral blood
mononuclear cells (PBMC) of CD patients compared with
controls (Po0.0001; Figure 4d). Because of the similarity in
LepRb production and CCR7 expression on gut DC, we
investigated their distribution in colonic tissue sections from
CD patients. Immunofluorescence microscopy revealed that
LepRb expression (green color) was abundant in the cytoplasm
of the epithelial cells and CCR7 positive cells (red color) were
scattered in the cytoplasm of the lamina propria cells. Co-
localization between LepRb and CCR7 was observed mainly in
the lamina propria (amber color, Figure 4e). Real-time PCR
methods also confirmed that LepRb mRNA levels were
significantly higher in enriched blood DC obtained from
patients with CD than from normal controls (Po0.008;
Figure 4f).
Expression of costimulatory/maturation molecules by
freshly isolated DC from the ileum and colon
To assess whether differences in expression of CCR7 and LepRb
were related to maturation status of DC in different gut
compartments, we checked the maturation status of DC in the
ileum and colon by comparing expression of costimulation and
maturation markers in freshly isolated cells and after overnight
culture, which is known to cause maturation of DC.25
Expression of costimulatory markers CD40, CD80, and
CD86 onDC from normal ileum and colon was compared. The
expression levels of these costimulatorymolecules were low and
comparable between DC from both intestinal compartments
indicating an immature phenotype (Figure 5a), in contrast with
the higher CD80 levels following overnight culture (Figure 5b).
We confirmed the immature phenotype of these DC in both
normal and inflamed colonic tissues by immunohistochemistry
and electronmicroscopy. Immunohistochemical investigations
showed that DC positive for DC-SIGN, a marker for immature
DC, were abundant in normal tissue and scattered evenly in the
lamina propria. However, in the inflamed tissue, DC-SIGN-
positive DC were significantly more abundant and located
mainly below the epithelium (Figure 6a andb). By contrast,DC
positive for DC-LAMP, a marker for mature DC, were few and
scattered evenly in the lamina propria of both types of tissues
(Figure 6c and d). Moreover, when labeled cells were counted,
the absolute numbers of DC-SIGN-positive DC were
significantly increased in colonic tissue from CD patients
compared with healthy controls. By contrast, there were no
significant differences between inflamed and normal colonic
tissues in the expression of DC-LAMP (Figure 6e and f).
Likewise, electron microscopy showed that in both types of
tissue the majority of DC were small cells with short veils
relative to their size, small cytoplasmic area, and heterochro-
matic nuclei with thick chromatin layer surrounding the
nucleus with chromatic dense clusters within the
nucleus, indicating that these cells are type 1 immature
DC26 (Figure 6g and h).
Collectively, these findings suggest that, in both normal and
inflamed tissues, immatureDCare predominant and, therefore,
the differences in expression of the CCR7 and LepRb were not
related to a different maturation status of the DC from the two
gut compartments.
A mechanistic role for leptin in CCR7 induction
When incubated with leptin for 4 h, the expression of CCR7 on
normal colonic DC was significantly increased (Po0.01;
Figure 7a). Chemotaxis assays demonstrated the
functionality of CCR7 by a concentration-dependent
increase in the migration of DC towards MIP-3b. By
contrast, low DC migration was observed in non-leptin-
stimulated lamina propria mononuclear cells (LPMC)
(Figure 7b).
Effects of CD colonic microenvironment on CCR7
expression and ongoing lepRb production in blood
DC
To further assess leptin-dependent CCR7 induction, we
investigated the effect of culture supernatant of biopsies from
CDpatients CD-SN (Crohn’s disease supernatant–conditioned
DC). Supernatants increased the expression of CCR7 on blood
DC, and this increase was significantly blocked by monoclonal
antibody against leptin receptor (Figure 8a and b).
DISCUSSION
The current study provides evidence that leptin stimulates DC
migration, via the long, signaling form of its receptor LepRb,
to induce functional CCR7 expression constitutively in the
normal human ileum, a mechanism absent in both the normal
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Figure 3 Ongoing production of LepRb (long isoform of leptin receptor)
by dendritic cells (DC) from normal blood and tissue. (a) Production of
LepRb on normal colonic tissue and normal ileum in paired samples from
the same individuals. (b) Expression of phosphorylation of signal
transducer and activator of transcription factor 3 (pSTAT3). Numbers
shown are the mean percentage of DC positive for LepRb±s.e.m.
**Po0.005 compared with normal colonic tissue.
ARTICLES
754 VOLUME 6 NUMBER 4 | JULY 2013 |www.nature.com/mi
colon and, systemically in mDC, in blood. By contrast, the
presence of high levels of both LepRb and functional CCR7 in
DC from the colon and blood in CD suggests a role for this
system in the development of inflammation; in normal colon
and blood DC, leptin promoted CCR7 expression and the
capacity of DC to migrate towards MIP-3b, a lymph node
chemokine, as previously reported in blood DC.20 A role for
leptin in CD is likely, as mesenteric hypertrophy of fat occurs
in early CD,27 accompanied by local increase in both the
adipokine leptin mRNA and protein.9 Involvement of leptin in
the colon in CD was further indicated by the upregulation of
CCR7 on DC by CD-SN, an effect blocked by antibody to
LepRb.
DC maturation is characterized by increases in surface
expression of co-stimulatory and adhesion molecules and
chemokines receptors, as well as secretion of cytokines,
chemokines and proteases.28 Flow cytometry and in situ
phenotyping of DC confirmed that, as in the normal colon,
immature DC were predominant in normal ileum, suggesting
that maturation induced by inflammation is not a prerequisite
for CCR7 and LepRb expression in ileum.
Although there is controversy in the literature,29 our data
indicate that DC from inflamed colonic tissue are also
predominantly immature, as determined by DC-SIGN and
DC-LAMP expression. Electron micrographs also confirmed
that themajority of DC in inflamed tissue were of the immature
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Figure 4 Ongoing production of LepRb (long isoform of leptin receptor) and C-Cmotif chemokine receptor 7 (CCR7) expression on dendritic cells (DC)
fromnormal individuals andCrohn’s disease (CD) patients. (a)CCR7expressionon colonicDC fromnormal andCD tissue (n¼14). (b) CCR7expression
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(red color) or co-localization (amber color) in the lamina propria of CDcolonic tissue. (f) Expression of LepRbmRNA inDCenriched fromblood of patients
with CD and normal individuals using real-time reverse transcriptase–PCR (n¼3). **Po0.001 and ***Po0.0001 comparedwith colonic DC fromhealthy
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phenotype, in line with observations inmurinemodels.30 These
in situ results also confirm that the increase in CCR7 expression
on colonic DC is independent of maturation during inflam-
mation. It is also possible that CCR7 is upregulated before full
maturation and exit of DC to lymph nodes.
There is an emerging consensus thatDCmaturation is not an
all-or-nothing phenomenon. For instance, when immature DC
were transfected with CCR7 in vitro, they acquired low levels of
co-stimulatory molecules, their migration capacity in response
to MIP-3b significantly increased, but their ability to stimulate
T cells was impaired,31 suggesting a semi-mature phenotype of
DC.32,33 Consistentwith this notion, the lower expression of co-
stimulatory molecules on fresh normal ileum and colonic DC
compared with those induced on maturation by overnight
culture suggest that the CCR7-positive DCwere of immature or
semi-mature phenotype; such immature cells would function to
induce T-cell anergy and, therefore, suppress T-cell-mediated
immune responses.34,35
The gut mucosa is constantly exposed to both commensal
and pathogenic foreign antigens, and DC are instrumental in
maintaining gut immune homeostasis. In response to patho-
genic antigens, DC initiate an immune response by processing
these antigens, maturing and migrating to local lymph nodes,
and stimulating T cells. DC sample antigens from the lumen,
either directly by passing dendrites through the epithelium36 or
indirectly by sampling antigen that is transported across
epithelial cells or captured by M-cells in the Peyer’s patches.
The small intestine is the section of the gut where nutrients are
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absorbed, and due to high flow rate and bile acid, themicroflora
concentration is relatively small compared with that in the large
intestine. Therefore, the differential expression of LepRb and
CCR7 on DC from the small and large intestine could be due to
the differentmicroenvironments in the two compartments. It is
likely that DC in healthy small bowel traffic constitutively to
draining lymph nodes to transport self-antigen, e.g., from
apoptotic cells, to induce oral tolerance, possibly, by promoting
tolerogenic naive T-cell profiles.37 Conversely, in the large
intestine, tolerance is maintained by the lack of DC migration;
migration of DC with upregulation of CCR7 in this compart-
ment may only occur upon encountering danger signals, to
induce immunogenic responses.
Our data have demonstrated a mechanistic role for leptin
as shown by the significant increase of CCR7 expression on
normal colonic DC when incubated with leptin. This
upregulation of CCR7 was functional as demonstrated by
the concentration-dependent migration of DC towards the
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Figure 6 Localization and numbers of DC-SIGN (a marker for immature dendritic cells (DC)) and DC-LAMP (a marker for mature DC) in normal and
inflammatory bowel disease colonic mucosae by immunohistochemistry. DC-SIGNþ immature cells were scattered evenly throughout the mucosa in
both (a) healthy controls and (b) Crohn’s disease (CD) tissues, with a tendency to cluster below the epithelium in CD tissues. DC-LAMPþ mature DC
were very few in number in both (c) control and (d) inflamed tissues andwere scattered in the lamina propria in all the tissue samples. (e) DC-SIGNþ DC
were significantly higher in CD tissues compared with controls. (f) DC-LAMPþ DC numbers were similar in both types of tissue. Electronmicrographs of
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chemoattractantMIP-3b. CCR7-dependentmigration requires
the JAK/STAT pathway asmature DCmigration towardsMIP-
3b and CCL20 in Jak3 / mice was impaired.38 Leptin shares
the same pathway but also activates the transcriptional factor
nuclear factor-kB, which mediates the upregulation of CCR7
expression.39,40 This activity may explain the effect of leptin on
CCR7 expression in DC from normal gut biopsies where the
production of LepRb was initially low. Indeed, leptin signaling
via LepRb also involves Src homology phosphatase 2 and
STAT5 among other downstream cascade of events.15 How-
ever, in this study, we focused on STAT3 known to be strongly
tyrosin phosphorylated in IBD41 and a mediator of inflamma-
tion in IBD and other forms of gut inflammation.42
Information on leptin concentrations in the serum of CD
patients is contradictory; while some reported no correlation
between plasma concentrations and the degree of inflammation
in patients with IBD,43 others have shown decrease in leptin
levels in the serum of IBD patients.44 These observations
suggest that the serum levels of leptin in IBD patients may be
affected by factors such as generalized loss of subcutaneous fat
and may not reflect increases in ‘‘local’’ mesenteric leptin
mRNA and protein levels in patients with IBD;45 patients with
CD are often thin but have fat mesentery. This anomaly could
be due to an endocrine or paracrine feed-back effect, from
the production of other adipokines that inhibit the leptin
production by adipocytes and other immune cells. For example,
resistin expressed by macrophages and circulating mononul-
clear cells increases the production of TNF-a and IL-6.46 TNF-
a subsequently downregulates the production of leptin by
adipocytes.47 It would be interesting to investigate whether IBD
patients with increased levels of leptin in the plasma have low
levels of TNF-a.
In conclusion, the coincident increase in CCR7 expression
and LepRb production in DC from inflamed tissues and
upregulation of CCR7 on DC following culture with leptin,
suggest that leptin has a role in regulating CCR7 and, hence, in
DCmigration from the gut as part of its role in inflammation in
CD. Our results suggest that leptin/leptin receptors could be
immunomodulatory therapeutic targets for the treatment of
CD; blocking of the upregulated leptin/CCR7 pathway in
colonic and systemic DC in CD might be invoked
therapeutically.
METHODS
Blood and tissues. The study was approved by the Outer West
London Regional Ethics Committee. All patients provided written
informed consent on entry to the study. Venous blood was obtained
from healthy volunteers and collected into heparinised Vacutainers
(BectonDickinson, Oxford, UK). Intestinal tissue was obtained during
routine endoscopy or from surgical resections. Non-inflamed tissue
was obtained from patients with macroscopically and histologically
normal intestine who had been referred with rectal bleeding or change
in bowel habit (endoscopic samples) and from patients at risk of
cancer. Inflamed tissuewas obtained frompatientswith IBD. Informed
consent was obtained from all patients and the local ethical committee
approved the protocols.
Antibodies. Antibodies to HLA-DR (G46-6), CD80 (L307.4), CD83
(HB15e), CD34 (581), CCR7 (2H4), pSTAT3 (4/pSTAT3) and CD8
(SK1-RPA-T8) and maching isotype control were purchased from BD
Pharmingen, Oxford, UK. Antibody to LepRb (Ob-Rb-COOH) and
(C20) were from Santa Cruz Biotechnology, CA, USA. Antibodies to
CD3 (UCHT-1), CD14 (MIP9), CD16 (B73.1), CD19 (4G7), andCD56
(N901) came from Beckman Coulter, High Wycombe, UK.
Antibodies toCD14 (TU¨K-4) andCD19 (SJ25-C1)were obtained from
ABD Serotec, Kidlington, UK. Anti-CD11c (clone KB90) was pur-
chased from Dako - Alere, Stockport, UK. Biotinylated anti-mouse
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IgM (R6-60.2) and phycoerythrin-conjugated streptavidin obtained
from BD Pharmingen. Anti-DC-SIGN/CD209-phycoerythrin, (120507)
was from R&D Systems, Abingdon, UK, and DC-LAMP/CD208
(104.G4) from Beckman Coulter. Appropriate isotype-matched
control antibodies were purchased from the same companies.
Blood processing and maturation of DC. PBMC were obtained by
centrifugation over Ficoll-Paque-Plus (Amersham Biosciences, Little
Chalfont, UK) at 650 g, for 30min at room temperature. To generate
mature blood DC, PBMC were cultured overnight (37 1C in humi-
dified 5%CO2) at 20 106/5ml in completemedium (Dutch-modified
RPMI 1640 (Sigma-Aldrich, Dorset, UK) containing 100 mml 1
penicillin/streptomycin, 2mM L-glutamine, 50 mgml 1 gentamicine
(Sigma-Aldrich), and 10% fetal calf serum (TCS cellworks, Buck-
ingham, UK)) in 25 cm2 tissue culture flasks (Becton Dickinson,
Oxford, UK). The cells were cultured overnight at 37 1C in humidified
5% CO2 and non-adherent cells recovered by centrifugation and DC
were identified by flow cytometery.
Isolation of LPMC. To obtain a fresh DC-containing LPMC popu-
lation with the minimal manipulation, a rapid collagenase digestion
method was used.25 To remove mucus, tissue was incubated at room
temperature for 20min, with occasional agitation, in calcium- and
magnesium-free HBSS (Hank’s Balanced Salt Solution; Life Tech-
nologies, Paisley, UK) containing 1mM dithiothreitol (Sigma-Aldrich,
Dorset, UK). Tissue was then blotted and transferred to HBSS
containing 1mM EDTA for removal of the epithelium. After incu-
bation at 37 1C for 30minwith gentle shaking, the tissuewaswashed in
HBSS repeatedly until the supernatant was macroscopically free of
released epithelial cells. Tissue denuded of epithelial cells was
incubated with gentle shaking at 37 1C inHEPES (4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid)-buffered RPMI-1640 (Sigma-
Aldrich) containing 1mgml 1 collagenase D, 20mgml 1 DNase I
(Roche, Burgess Hill, UK) and 2% fetal calf serum. Incubation
was stopped when visual inspection revealed complete digestion of the
tissue, typically after 90–120min. Mononuclear cells were then
separated (650 g, 20min, room temperature.) on Ficoll-Paque
(Amersham Biosciences, Little Chalfont, UK) and washed in complete
medium.
Cell surface labeling. For whole-blood staining, antibodies were
added to 100ml of blood at predetermined optimal concentrations and
incubated at room temperature for 15mins. Cells from intestinal
tissues were antibody-labeled in 100 ml FACS buffer on ice for 20min
in the presence of 15% fetal calf serum to reduce non-specific binding.
To determine the effect of leptin on CCR7 expression on blood and
tissue DC, leptin was incubated with PBMC or LPMC for 4–6 h at a
concentration of 20 nM. CCR7 expression on DCwas then determined
using multi-color flow cytometer (FACSCalibur, BD, UK).
Intracellular labeling. The production of LepRb by Blood DC and
LPDC was determined as previously discribed.48 Briefly, LPMC and
PBMC were placed in wells at 5 105 cells per well in 1-ml complete
medium in Falcon 24-well tissue culture plates (Becton Dickinson).
LPMC were incubated with and without monensin (3mmol l 1) for
4 h at 37 1C in a humidified atmosphere of 5% CO2 in air. Monensin
leads to the accumulation of protiens at the Golgi apparatus. Cultured
cells were then washed, fixed with Leucoperm A (100mL), and
permeabilized with Leucoperm B (50ml; ABD Serotec, Kidlington,
UK). Cells were then incubated with anti-LepRb, pSTAT3, or isotype
control (IgG2a-phycoerythrin for 30min,washed, then incubatedwith
antimouse FITC-conjugated IgG for 20min, washed and finally
resuspended in 1% paraformaldehyde. By using themonensin method
and applying the same antibody to stain both samples in a comparison,
the potential problems associated with differences between antibodies
with regard to non-specific binding to permeablised cells (for instance,
due to variations in free fluorochrome content) were avoided; the
techniquewas thus very sensitive. The results are presented graphically
as a histogram of the staining in the presence of monensin in which a
shaded area represents the fraction of positive cells after subtraction of
the no monensin labeling. The differences between the paired his-
tograms were determined as shown below.
Flow cytometry and data analysis. Data were acquired on a four-
color FACScalibur machine (Becton Dickinson). List mode data files
were analyzed usingWinList-5.0 software (Verity, Topsham,ME). DC
were identified as HLA-DRþ Lin cells where Lin is a mixture of
monoclonal antibodies to CD3, CD14, CD16, CD19 CD34, and CD56.
The mDC was identified as a CD11cþ subset; plasmacytoid DC were
CD11c . To determine expression of othermarkers, single parameter
histogram plots were prepared for gated DC populations. Histograms
of isotype control labeling were subtracted from histograms of specific
antibody staining using the Super-enhanced Dmax normalized sub-
traction (SED) facility in WinList. The statistical significance of
differences between the two curves were assessed by Kolmogorov and
Smirnov (K–S) statistics according to the formula:49
Dcrit¼Dmax=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
fðn1þ n2Þ=ðn1xn2Þg
p
where Dmax is the maximum difference between cumulative nor-
malized histograms of isotype control and antibody labeling, n1 is the
number of events in the antibody-labeled sample, and n2 is the
number of events in the isotype-matched control sample.
Samples with an insignificantDcrit value (P40.05, K–S statistics), or
where the subtraction program suggests a negative value (i.e., there is
greater labeling with the isotype control), were regarded as zero.
Results are presented as the percentage of positive cells after
subtraction of the isotype control. The statistical significance of
differences between experimental groups was determined using t-tests
and Po0.05 was regarded as significant.
Chemotaxis assay. Chemotactic responses to chemokines were
analyzed in a 5-mm Transwell system (Corning, Lowell, MA) using a
membrane pore size of 5-mm. In a volume of 100 ml, 5 105 PBMC or
LPMC were placed in the upper chamber of the Transwell. Into the
bottom chamber was placed 600ml at concentrations of 0.05mgml 1,
0.5mgml 1 and 5mgml 1 of the chemokine in complete medium.
Control wells contained medium alone. Plates were incubated for
90min at 37 1C in humidified 5%CO2 andmigrated cells recovered by
centrifugation. The number of migrating cells was determined by flow
cytometry using flow count fluorospheres (Beckman Coulter, High
Wycombe, UK) to determine cell numbers. DC were detected by
antibody labeling as described above.
Enrichment of DC from PBMC. DC-enriched (LDC (low-density
cells)) were generated as previously described50 and consistently gave a
yield of 5–7% of the total number of PBMC isolated from all donors.
Briefly, PBMC were incubated for 24 h (at 37 1C, 5% CO2, high
humidity) in complete medium (Dutch-modified RPMI 1640 (Sigma-
Aldrich) containing 100 mml 1 penicillin/streptomycin, 2mM
L-glutamine, and 10% fetal calf serum (TCS cellworks, Buckingham,
UK) at 4 106ml 1 in T25 tissue culture flasks. Non-adherent cells
were centrifuged (600 g, 15min at room temperature) over NycoPrep
(Progen Biotechnik, Heidelberg, Germany), and LDC recovered from
the interface, washed, counted and lysed in 1ml lysis buffer (Miltenyi
Biotec, Bisley, UK) and stored at  80 1C.
DC conditioning. Colonic biopsies from four CD patients were
collected in ice-chilled complete medium and cultured within 1 h in
complete medium in 24-well culture dishes (1 biopsy per ml per well)
for 24 h (37 1C, 5% CO2, high humidity). In addition, 1ml of complete
medium was added to empty wells and incubated for use as a control.
Media were centrifuged (1500 r.p.m., t¼ 50), and supernatants used to
condition freshly isolated PBMC. PBMC were incubated at (1 million
cellsml 1) in the culture medium from colon biopsies or control.
Conditioned PBMCwere incubated with anti-lepRb at concentrations
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of 0.01 mgml 1, 0.1 mgml 1, and 1 mgml 1 for 4 h. DC were
identified as described above and CCR7 on DC was analyzed.
Semi-quantitative reverse transcriptase PCR. The lysed cells were
thawed and RNA was isolated using the mmacs small-scale mRNA
isolation kit (Miltenyi Biotec, UK). Reverse transcription was per-
formed using the Invitrogen Cloned AMV First Strand cDNA
Synthesis Kit (Invitrogen, Paisley, UK).
The primers were obtained from Invitrogen and sequences were as
follows:
The primers were designed so that the regions amplifiedwould cross
exons and therefore any genomic DNAwould not be amplified during
PCR. Blast searches were performed to ensure that the amplified
sequences only corresponded to the desired genes. The primers were
obtained from Invitrogen Life Technologies and sequences were
as follows: LepRb: forward, 50-GTTCCGAACCCCAAGA-30, reverse,
50-CCACAGTTGTTGGCAT-30; and UbcH5B (housekeeping gene):
forward, (50-AGTGTTCAGCAGGTCC-30, reverse, 50-TCCGAG-
CAATCTCAGG-30. Real-time reverse transcriptase–PCR was used
using the FastStart SYBR Green method with the Roche Light Cycler
(Roche Applied Science, Burgess Hill, UK) following the manufac-
turer’s protocol and using the following conditions: 95 1C for 10min 1
cycle; 95 1C for 10 s; 60 1C for 5 s 45 cycles; and 72 1C for 8 s. The
relative quantification software was used to quantify the expression
of each test gene relative to the housekeeping gene for each sample.
This was done with reference to a calibration curve for each gene so
that the efficiency of the reaction could be taken into account by
the software.
Immunohistochemistry. The avidin–biotin complex technique was
used. Briefly, slides of paraffin-embedded tissue sections of colonic
biopsies were deparaffinised, rehydrated, and endogenous peroxidase
activity was blocked with 0.3% H2O2 in 100% methanol for 30min.
Tissues were then incubated with normal goat serum for 30min at
room temperature and incubated overnight in a humid atmosphere
at 4 1C, with primary antibodies, anti-DC-LAMP (1:50) and anti-DC-
SIGN (1:200). After washing and incubation with biotinylated goat
anti-mouse immunoglobulin for 30min, sections were washed and
incubated with the avidin–biotin-peroxidase complex. Subsequently,
sections were washed in tap water, counterstained with haematoxylin,
placed in acid alcohol for 3–5 s, and washed in water. Sections were
dehydrated, cleared in xylene, and finally mounted with DEPEX.
Red-brown staining indicates positive immunoreactivity. Control
sections were incubated with normal serum instead of primary
antibodies. All incubation times were similar and reactions were
stopped simultaneously on sections to standardize the quantitative
methods.
For quantification of antibody staining, all positive cells in every
possible microscopic field in all sections were counted under high-
power magnification ( 40 objective). To enable comparison between
sections of different sizes, results were expressed as number of positive
cells per 10 microscopic fields. Only morphologically well-defined
positively stained cells were considered for analysis. All assessments of
immunostaining were independently evaluated by two investigators
who had no previous knowledge of the clinical data.
Immunofluorescence microscopy. Double labeling was performed
on 4 mM frozen section. Sections were fixed in cold acetone, washed
with phosphate-buffered saline (PBS), incubated with normal mouse
serum (NMS), and incubated with anti-lepRb (1:500) for overnight.
After three washes in PBS, sections were incubated withNMS followed
by anti-mouse FITC IgG for 3 h. Sections were incubated with NMS
followed by anti-CCR7 (R&D Systems, UK) for 3 h, then washed with
PBS, and non-specific binding was blocked with NMS before incu-
bation with TRITC-conjugated secondary antibody (Sigma). Sections
were washed and mounted under cover slips with mounting medium
(Dako, UK). Control experiments were performed by omitting the
primary antibodies.
Electron microscopy. Ultrathin sections of colonic tissues (100-nm
thick) were were stained with Reynold’s lead citrate, the grid was
carbon coated, and visualized using a JEOL 1200 EX electron
microscope (JEOL, Tachikawa, Japan). DC were identified as pre-
viously described51 andhave been classified into three types by electron
microscopy: Type 1—myeloid iDC,small cells with short veils relative
to their size, small cytoplasm area, and heterochromatic nuclei with
thick chromatin layer surrounding the nucleus and chromatic dense
clusters within the nucleus; Type 2—possible plasmacytoid DC, are
bigger than type-1, with fewer projections, thin chromatin layer
surrounding the nucleus, and disaggregated chromatin within the
nucleus; and Type 3—mature mDC, have long veiled projections.
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